Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Other Non Operating Income: 2020-2024

Historic Other Non Operating Income for NewAmsterdam Pharma Co N.V (NAMS) over the last 5 years, with Dec 2024 value amounting to $38.6 million.

  • NewAmsterdam Pharma Co N.V's Other Non Operating Income rose 408.16% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.2 million, marking a year-over-year decrease of 0.73%. This contributed to the annual value of $38.6 million for FY2024, which is 285.14% up from last year.
  • Per NewAmsterdam Pharma Co N.V's latest filing, its Other Non Operating Income stood at $38.6 million for FY2024, which was up 285.14% from $10.0 million recorded in FY2023.
  • NewAmsterdam Pharma Co N.V's 5-year Other Non Operating Income high stood at $38.6 million for FY2024, and its period low was -$9.7 million during FY2022.
  • In the last 3 years, NewAmsterdam Pharma Co N.V's Other Non Operating Income had a median value of $10.0 million in 2023 and averaged $13.0 million.
  • Per our database at Business Quant, NewAmsterdam Pharma Co N.V's Other Non Operating Income surged by 6,225,592.72% in 2021 and then crashed by 671.34% in 2022.
  • Over the past 5 years, NewAmsterdam Pharma Co N.V's Other Non Operating Income (Yearly) stood at $27.40 in 2020, then spiked by 6,225,592.72% to $1.7 million in 2021, then plummeted by 671.34% to -$9.7 million in 2022, then surged by 202.78% to $10.0 million in 2023, then surged by 285.14% to $38.6 million in 2024.